POLYNEUROPATHIES
Clinical trials for POLYNEUROPATHIES explained in plain language.
Never miss a new study
Get alerted when new POLYNEUROPATHIES trials appear
Sign up with your email to follow new studies for POLYNEUROPATHIES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can a daily pill keep a rare heart disease in check for the long haul?
Disease control Not yet recruitingThis study tests the long-term safety and tolerability of acoramidis, an oral medication that stabilizes the transthyretin protein, in people newly diagnosed with transthyretin amyloid cardiomyopathy (ATTR-CM), a condition that can lead to heart failure. Participants who complete…
Matched conditions: POLYNEUROPATHIES
Phase: PHASE3 • Sponsor: Eidos Therapeutics, a BridgeBio company • Aim: Disease control
Last updated Aug 13, 2026 00:00 UTC
-
A muscle protein may signal nerve damage in diabetes — study puts it to the test
Knowledge-focused Not yet recruitingThis study investigates whether blood levels of irisin, a protein linked to glucose metabolism and nerve protection, differ in people with type 2 diabetes who have diabetic polyneuropathy (nerve damage) compared to those without it and healthy controls. Researchers will measure i…
Matched conditions: POLYNEUROPATHIES
Sponsor: GÜLDEN ANATACA • Aim: Knowledge-focused
Last updated Jul 31, 2026 00:00 UTC
-
Could your age change how a nerve test reads your nerves?
Knowledge-focused Not yet recruitingThis study looks at whether a person's age influences the accuracy of a nerve test called the sural-to-radial amplitude ratio (SRAR) in telling apart two types of peripheral neuropathy: length-dependent and non-length-dependent. Researchers will review medical records from about …
Matched conditions: POLYNEUROPATHIES
Sponsor: Centre Hospitalier Universitaire de Nice • Aim: Knowledge-focused
Last updated Jul 26, 2026 00:00 UTC